Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
9,09 USD | 0,00 % | -0,76 % | -18,98 % |
Resumen de negocios
Número de empleados: 29
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07/07/09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/07/09 |
Chief Tech/Sci/R&D Officer | - | - | |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25/04/14 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 01/11/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 25/08/11 |
Khalid Islam
CHM | Chairman | 67 | 25/04/14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25/04/14 |
Marco Brughera
BRD | Director/Board Member | 70 | 10/08/16 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07/07/09 |
Jodi Cook
BRD | Director/Board Member | 56 | 24/09/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 27 099 908 | 22 955 300 ( 84,71 %) | 0 | 84,71 % |
Información de la empresa
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-18,98 % | 246 M | |
-1,65 % | 104 mil M | |
+6,75 % | 97,47 mil M | |
+5,71 % | 22,25 mil M | |
-12,60 % | 21,68 mil M | |
-9,70 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-10,17 % | 16,36 mil M | |
+6,12 % | 14,39 mil M | |
+35,47 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción FENC
- Empresa Fennec Pharmaceuticals Inc.